MarketWise Announces Appointment of Dr. David Eifrig as Chief Executive Officer
BALTIMORE, May 27, 2025 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) ("MarketWise" or "the Company"), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for investors, today announced that Dr. David "Doc" Eifrig has been appointed Chief Executive Officer of the Company on a permanent basis, effective immediately. Dr. Eifrig has served as interim Chief Executive Officer since August 2024.
Dr. Eifrig has overseen notable achievements during his tenure as interim CEO, including improved financial performance over the last two quarters. He has demonstrated a clear vision for the company's future while earning the confidence of the Board of Directors, employees, and shareholders alike.
Matthew Turner, Chairman of the MarketWise board of directors remarked, "We're very pleased to have Doc at the helm in a permanent status. We believe his steady emphasis on the fundamentals of the business will bear long and steady profits for shareholders."
Dr. Eifrig commented, "I am honored and excited to continue leading MarketWise as we build on our momentum and pursue new opportunities. This company has an extraordinary team and an unwavering commitment to delivering value to our customers, partners, and shareholders. I look forward to working alongside our talented employees to shape a strong and sustainable future for MarketWise. Just as importantly, I want to spread the idea that individuals can control their investing, their wealth, and their life path in a beautiful and success-filled way."
Dr. Eifrig received his Bachelor of Arts from Carleton College in Minnesota. He later received a Master of Business Administration degree from Northwestern University's Kellogg School of Management, graduating with a double major in finance and international business. He went on to work for Goldman Sachs in its first derivatives group in New York and London.
Dr. Eifrig subsequently earned his M.D. from the University of North Carolina at Chapel Hill and completed a Molecular Biology Fellowship at Duke University. He's a published peer-reviewed scientist as well. He finished a residency in ophthalmology before joining the company full time in 2008.
Dr. Eifrig first consulted with the Company in 2004 before joining full-time several years later. Today, he remains one of its most prolific editors. He launched his health and wealth advisory Retirement Millionaire in early 2009; with tens of thousands of subscribers getting access to real world insights on personal health and wealth creation over the past three decades. His option trading advisory called Retirement Trader, which began in 2010, helped put option selling on the map and arguably has one of the best track records of all time. His conservative but dearly loved letter Income Intelligence shows folks of any age how to invest for income and not speculation. He himself professes to be a lifelong information junkie.
Dr. Eifrig has also served as a member of the MarketWise Board since May 2023.
About MarketWise
Founded with a mission to level the playing field for self-directed investors, today MarketWise is a leading multi-brand subscription services platform providing premium financial research, software, education, and tools for investors.
With 25 years of operating history, MarketWise is currently comprised of 11 primary customer facing brands, offering more than 140 products, and serving a community of over 3 million free and paid subscribers. MarketWise's products are a trusted source for high-value financial research, education, actionable investment ideas, and investment software. MarketWise is a 100% digital, direct-to-customer company offering its research across a variety of platforms including mobile, desktops, and tablets. MarketWise has a proven, agile, and scalable platform and our vision is to become the leading financial solutions platform for self-directed investors.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the Company's ability to capitalize on growth opportunities. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including those described in the "Risk Factors" section of our filings with the U.S. Securities and Exchange Commission (the "SEC"), including our Annual Report on Form 10-K for the year ended December 31, 2024.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
These Were the 2 Worst-Performing Stocks in the Dow Jones Industrial Average in May 2025
The Dow Jones Industrial Average (DJINDICES: ^DJI) index edged 3.9% higher in May, with 70% of its 30 constituent stocks ending the month in positive territory. However, the two worst-performing Dow stocks in May -- both from the healthcare sector -- kept the index's rally in check, with one of them plunging over 25%. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » 1. UnitedHealth Group Shares of UnitedHealth Group (NYSE: UNH) crashed 26.6% in May after multiple negative developments sent shockwaves through the investing community. In mid-May, UnitedHealth suddenly replaced its CEO, Andrew Witty, with former CEO Stephen J. Hemsley with immediate effect and suspended its earnings outlook for the full year because of a surge in medical costs. In between, The Wall Street Journal reported a criminal investigation against UnitedHealth by the Department of Justice for a "possible medicare fraud." Days later, The Guardian released a scathing report alleging UnitedHealth put patients' health at risk by paying secret bonuses to nursing homes to cut hospital transfers. For now, UnitedHealth expects to "return to growth" in 2026 and has sued The Guardian for defamation. Regaining investor confidence, however, may not be easy. The stock is down 38% so far this year, as of this writing. 2. Merck Merck (NYSE: MRK) stock lost 9.8% in May and plunged to its 52-week low of $73.31 a share after President Donald Trump signed an executive order directing drugmakers in the U.S. to cut the prices of prescription drugs. This comes at a time when Merck already expects tariffs to add $200 million to its costs this year. Investors are also worried about Merck's future once its blockbuster oncology drug Keytruda loses patent exclusivity. In mid-May, analysts at Citi slashed Merck stock's price target to $84 per share from $115 per share citing the pharmaceutical company's growth challenges and a "lack of urgency" to develop a business that could soften the impact of a potential loss of up to 20% of sales for Keytruda once its patent expires. Merck, however, has a strong pipeline, remains committed to dividend growth, and yields 3.9%. Should you invest $1,000 in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $655,255!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $888,780!* Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
Globe and Mail
2 hours ago
- Globe and Mail
Should You Buy Nvidia? These Chip Stocks Are Soaring as AI Demand Remains Hot.
Nvidia (NASDAQ: NVDA) continues to dominate the lion's share of the chips going into data centers for artificial intelligence (AI). The company just reported another monster quarter of growth, and the stock is closing in on new all-time highs. There's still a case for buying Nvidia stock, but investors shouldn't put all their chips in one basket (no pun intended). Nvidia is not capturing all the demand for AI semiconductors. Hyperscalers like Alphabet 's Google and Amazon are designing custom chips for specific AI workloads in their cloud services, and this is creating tremendous growth for other leading semiconductor companies. Shares of Broadcom (NASDAQ: AVGO) and Taiwan Semiconductor Manufacturing (NYSE: TSM) recently were up 73% and 29%, respectively -- both outperforming Nvidia's 18% return over the last year. These chip stocks can broaden your exposure to the growing demand for AI chips across the data center market. 1. Broadcom Broadcom is a top supplier of custom AI accelerators (XPUs) and networking solutions for data centers and other markets. Its networking business supplies components that help move data at high speeds, which is vital as hyperscalers shift to more advanced AI workloads. Broadcom has reported five consecutive quarters of 20% or more revenue growth. Specifically, AI-related revenue jumped 46% year over year in the most recent quarter. Broadcom is turning this growth into strong profits, with free cash flow reaching $6.4 billion last quarter, representing a high 43% margin on revenue. AI networking revenue, including Broadcom's Ethernet networking products, grew 170% year over year, representing nearly half of its total revenue from AI. This incredible growth in networking signals a massive ramp in computing power to create the next wave of AI applications and services. Broadcom is also supplying XPUs, which are more cost-efficient for specific workloads than Nvidia's general-purpose chips. Broadcom sees at least three customers deploying 1 million custom AI-accelerated clusters by 2027, and it reported on the last earnings call that these large hyperscalers are "unwavering" in their plans to continue investing in the near term. The long-term outlook for custom chip demand should support shareholder returns over the next several years. In fact, management expects custom XPU demand to accelerate through 2026. The stock isn't cheap, trading at a forward price-to-earnings multiple of 38, but the opportunity could justify the premium. 2. Taiwan Semiconductor Manufacturing Taiwan Semiconductor Manufacturing (also known as TSMC) plays a vital role in the global supply chain for the chip industry. It's the largest chip foundry, with more than 65% market share, according to Counterpoint. It makes chips for several companies, including Nvidia, Broadcom, Advanced Micro Devices, and Apple, as well as hyperscalers. The stock is surging to new highs following a monster quarter, during which revenue in U.S. dollars grew 35% year over year. This strong growth was despite weak smartphone revenue in the quarter, representing over a quarter of the company's revenue, due to seasonal demand trends. TSMC has spent decades investing in cutting-edge chip-making technology to meet customer needs for the world's most advanced chips. Its competitive advantage is based on superior manufacturing capabilities and massive chip-making capacity, enabling it to make more than 16 million 12-inch equivalent wafers annually. These advantages enabled TSMC to earn a sky-high profit margin of 41% on a trailing-12-month basis. TSMC is planning to double its chip-on-wafer-on-substrate (CoWoS) capacity in 2025, indicating growing support for the demand that Nvidia and other customers are experiencing. TSMC recently announced a substantial investment of $165 billion to launch new manufacturing facilities in the U.S., in addition to expansion plans in other geographies. AI accelerator revenue tripled in 2024, and management expects it to double in 2025. Through 2029, the company expects demand for AI chips to grow at an annualized rate topping 40%. Taiwan Semiconductor shares may be the best value among chip stocks right now. The stock trades at just 23 times 2025 earnings estimates, despite analysts expecting 21% annualized earnings growth. While earnings multiples above 20 are historically expensive for chip stocks, these companies are experiencing a once-in-a-generation growth spurt that will likely deliver excellent returns to investors through the end of the decade. Should you invest $1,000 in Broadcom right now? Before you buy stock in Broadcom, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Broadcom wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $655,255!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $888,780!* Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. John Ballard has positions in Advanced Micro Devices and Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Apple, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Broadcom. The Motley Fool has a disclosure policy.
Globe and Mail
2 hours ago
- Globe and Mail
2 Top Cybersecurity Stocks to Buy in June
Cybersecurity is one industry that doesn't take a break. Hackers become more dangerous every year, so ensuring that a company has a top-notch cybersecurity protection plan is critical. This makes it an excellent industry to invest in, as it's practically recession-proof. Most companies will find many other places to cut expenses before they trim their cybersecurity budgets. The industry is large, and there are multiple facets to a rock-solid cybersecurity plan, which is why many companies utilize services from multiple vendors. As a result, there are multiple great cybersecurity companies to invest in. Two that I think are solid buys right now are SentinelOne (NYSE: S) and Okta (NASDAQ: OKTA). 1. SentinelOne SentinelOne offers AI-first endpoint protection software. Endpoints are all the devices that can access a company's network, like smartphones or laptops. If a bad actor can access a network through one of these devices, they can have free rein over the company's data, which could be a disaster. SentinelOne is just one competitor among many in the endpoint protection space, but its most notable peer is CrowdStrike (NASDAQ: CRWD). I've been a CrowdStrike bull for a long time, but given how expensive the stock has become, it's just not a buy today. Shares of SentinelOne, which offers a similar product, are much more reasonably priced, and the company is achieving strong growth. The best metric to use when evaluating both companies is the price-to-sales (P/S) ratio, as neither is reliably profitable yet. S PS Ratio data by YCharts. At 6.7 times sales, SentinelOne is cheap for a software stock, as most software companies trade between 10 and 20 times sales. CrowdStrike is at the high end of that range; however, it's not growing as fast as SentinelOne. Both companies' fiscal 2026 first quarters ended on April 30. During that quarter, CrowdStrike's revenue grew 20% year over year to $1.1 billion and its annual recurring revenue (ARR) rose 22% to $4.44 billion. SentinelOne's revenue rose 23% to $229 million, while its ARR increased by 24% to $948 million. The differences in valuation between these two largely come down to two factors. First, CrowdStrike is a much larger business and has already captured a significant chunk of the cybersecurity market. Second, CrowdStrike appears close to achieving consistent profitability. SentinelOne is light years away from doing so. However, SentinelOne has been more focused on growing its top line. If management flips the switch and focuses on profitability instead, it could close the red ink gap. I think the stock price is cheap enough and the business is strong enough that SenitelOne could be a solid buy here. Just don't expect it to turn profitable anytime soon. 2. Okta Okta plays in a completely different cybersecurity realm: It's an identity and access management specialist that ensures that a system's users are legitimate, and that each one can only access the information and apps they are supposed to be able to. For example, if a client didn't have robust enough endpoint protection or a bad actor somehow got through that layer of security using stolen credentials, they would only gain access to the limited parts of the system that the user was supposed to be able to access. Furthermore, Okta also monitors for unusual activity and can easily detect when someone is acting suspiciously. Okta is a key IT component in large organizations and a smart cybersecurity investment. Its P/S ratio of 6.7 is quite cheap, too. However, it's not growing nearly as fast as SentinelOne: Okta's revenue was up just 12% year over year in Q1. But its remaining performance obligation (similar to ARR) rose by an outstanding 21%. One thing that sets Okta apart is its solid profitability. In the past three years, it has climbed the ladder from deep unprofitability (similar to where SentinelOne's margins are) to producing positive net income. OKTA Profit Margin data by YCharts. Okta still has plenty of potential to produce even stronger margins -- software companies can easily reach 20% to 30% profit margins. If it does, the stock could be a monster winner thanks to its low current valuation. Should you invest $1,000 in SentinelOne right now? Before you buy stock in SentinelOne, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and SentinelOne wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $655,255!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $888,780!* Now, it's worth noting Stock Advisor 's total average return is999% — a market-crushing outperformance compared to174%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
